Reports for TEVA-KETOCONAZOLE
Brand name
TEVA-KETOCONAZOLE
Company Name
TEVA CANADA LIMITED
|
Drug Identification Number
02231061 |
Ingredients
KETOCONAZOLE |
Ingredient Strength
200 MG |
ATC Code
J02ABJ02AB |
ATC Descriptor
ANTIMYCOTICS FOR SYSTEMIC USE ANTIMYCOTICS FOR SYSTEMIC USE |
Status
MARKETED
|
Shortage reports
| Brand name | Packaging Size | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|
| TEVA-KETOCONAZOLE | 100 | Resolved | 2017-04-03 | 2017-09-06 | 5201 |
| TEVA-KETOCONAZOLE | 100 | Resolved | 2020-02-13 | 2020-04-09 | 106021 |
| TEVA-KETOCONAZOLE | 100 | Resolved | 2020-09-24 | 2020-11-07 | 124977 |
| TEVA-KETOCONAZOLE | 100 | Resolved | 2021-01-22 | 2021-09-02 | 132261 |
| TEVA-KETOCONAZOLE | 100 | Resolved | 2022-02-17 | 2022-05-26 | 155177 |
| TEVA-KETOCONAZOLE | 100 | Resolved | 2024-07-04 | 2024-09-05 | 232201 |
| TEVA-KETOCONAZOLE | 100 | Resolved | 2024-07-04 | 2024-07-04 | 232203 |
| TEVA-KETOCONAZOLE | 100 | Actual shortage | 2025-07-18 | 2025-12-04 | 263125 |
Showing 1 to 8 of 8
Discontinuation reports
| Brand name | Packaging Size | Status | Date Created | Date Updated | Reports |
|---|
Showing 1 to 0 of 0